We are proud to share that @alanawelm.bsky.social, PhD, has been named chair of Oncological Sciences at @utah.edu. A global leader in breast cancer research, she brings deep vision, collaboration, and impact to this new role. Please join us in congratulating Dr. Welm. Learn more: bit.ly/3H3GqB3
Photo of the Block U on the hill with blooming trees in the foreground.
Happy Monday! 🌸
Congratulations!
Academic research essentially on hold in 70 health fields like "gene regulation in cancer" and "tumor evolution, heterogeneity, and metastasis."
The Trump administration's efforts to slash research funding have US graduate students, postdocs and other early-career scientists fearing for their careers. Some might leave the country -- or abandon research altogether.
https://go.nature.com/43ao2zq
Almost all grant-review meetings remain suspended at the US National Institutes of Health, preventing the world’s largest public funder of biomedical research from spending much of its US$47 billion annual budget.
https://go.nature.com/418B5Pm
The National Institutes of Health had to stop considering new grant applications, delaying funding for research into diseases ranging from heart disease and cancer to Alzheimer's and allergies.
a helpful study looking at HMA+VEN vs IC induction in newly diagnosed CBF-AML
-no significant difference in CR within inv16 group
-significantly higher CR rates with IC within t(8;21) group
-limited discussion regarding subsequent consolidation after induction
www.nature.com/articles/s41...
Exciting news! Dr. Anna Parks has received the ASH Junior Faculty Scholar Award, recognizing her outstanding research in hematology. This award supports her work in improving care for older adults with blood disorders. Congratulations, Dr. Parks, on this well-deserved honor! bit.ly/3D3lx7t
Do AML-based risk scores hold up for MPN-AP/BP treated w/ less-intensive therapy @bloodportfolio.bsky.social? We found:
-ELN24 had most robust performance for OS (C-index: 0.60)
-more work needs to be done to specifically develop risk scores for MPN-AP/BP!
ashpublications.org/bloodadvance...
As President Trump pursues his right-wing agenda at breakneck speed, with Democrats in retreat and “Never Trump” conservatives making themselves scarce, Utah's center-right Republicans are trying to reassert themselves.
In 2024 I shared a poem in JAMA Onc on giving bad news & the pain of loss when a child dies. It's the worst part of my job.
Cutting research & global aid funding + firing scientists, clinicians, & public health professionals = more children die.
Our leaders have my patients' blood on their hands.
Very excited to share our review in CLML re challenging MPN scenarios! We focus on:
-incorporation of molecular mutations into allo-HCT consideration in MF
-splenomegaly in JAKi-treated patients
-treatment options for MPN-AP/BP
www.clinical-lymphoma-myeloma-leukemia.com/article/S215...
tagging some MPN peeps!
@mpndoc.bsky.social @nicogagelmann.bsky.social @rubenmesamd.bsky.social @alexrampotas.bsky.social @raajitrampal.bsky.social @amibpatelmd.bsky.social @aarongerds.bsky.social @matteodragani.bsky.social @jdbeckman.bsky.social @pedshemedoc.bsky.social @mullallylab.bsky.social
I get the sentiment but it doesn’t read as such.
No,Utah is not the very baddest of places. You are wrong.
Is this bill despicable? Yes. Unequivocally. Updated article below. www.sltrib.com/news/politic...
I really hope foundation grants become a lot less biased/inbred. We need to be scrutinizing members of medical/scientific advisory boards against awardees.
This week on #SimplyBlood, we're highlighting the Patel Lab (@AmiBPatelMD.bsky.social) out of the University of Utah/Huntsman Cancer Institute. Read to learn more about their research, challenges, and most rewarding times in the lab. https://buff.ly/3wJDqVM
Yes, working now 😵💫
Can’t log into eRA Commons
